University of California San Diego (UCSD)
La Jolla, California, 92093-0934, United States
NCT Number: NCT07225933
This is a retrospective, multi-center collaboration to assess real-world outcomes of a novel steerable aspiration system, the CVAC® System ("CVAC"), and flexible and navigable suction ureteral access sheath (FANS) for the treatment of urinary stones.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
La Jolla, California, 92093-0934, United States
The objective of this study is observation of the safety and efficacy of subjects who underwent SURE procedure using the CVAC System or FANS for the removal of kidney stones in candidates for URS with laser lithotripsy. Efficacy will be observed by reviewing stone free status on standard of care post-procedure imaging. Safety will be observed by reviewing procedural information and if subjects had urologic events leading to Emergency Department (ED) visits, hospitalization, or retreatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).
Other names: SURE, CVAC
FANS is designed to incorporate suction to facilitate stone fragment removal through its lumen and is used with a separate ureteroscope. FANS is fitted with a Y connector with a pressure control vent and connects to a standard vacuum device. A separate ureteroscope provides direct visualization and irrigation and a separate specimen collector captures stone debris.
Other names: FANS, fURS
Time frame: Post-Operative up to 90 Days
Completed by reviewing any available standard of care post-procedure imaging
Time frame: Intra- & Post-Operative up to 90 Days
Completed by reviewing data available for intra- and post-op complications
Calyxo, Inc.
Industry
Acronym: REASON
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02028559
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT06412900
Calculi, Female Urogenital Diseases
Oslo, Norway
View Trial DetailsNCT07101809
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07712861
Calculi, Female Urogenital Diseases
Buenos Aires, Argentina
View Trial Details